Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma
Open Access
- 14 March 2022
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 11 (14) , 2855-2864
Abstract
Background: This study aims to reveal the serum tumor marker (STM) levels in lung adenocarcinoma (LUAD) histological subtypes and evaluate their values in predicting the solid and micropapillary components (SMC).Methods: We retrospectively analyzed 3100 invasive LUAD patients between January 2017 and December 2020. Associations between preoperative STMs (CEA, CYFRA21‐1, CA199, CA724, NSE, AFP) and LUAD subtypes were evaluated. Multivariate regression analyses were used to determine the independent predictors. Predictive models for SMC were constructed and AUC (area under the curve) was calculated.Results: CEA and CYFRA21‐1 levels differed across the LUAD histological subtypes, with the SPA (solid‐predominant adenocarcinoma) having the highest level and the LPA (lepidic‐predominant adenocarcinoma) harboring the lowest level (p p = 0.009; validation set: 0.747, p = 0.034). The AUC of the model for micropapillary component with only gender and tumor size was 0.699 and 0.711 in the training set and validation set, respectively. Integration of CEA with gender and tumor size significantly improved the predictive performance with an AUC of 0.746 (training set, p = 0.045) and 0.753 (validation set, p <0.001).Conclusion: Serum CEA and CYFRA21‐1 varied considerably according to LUAD histological subtypes. The combination of serum CEA and other factors showed prominent values in predicting the SMC.Keywords
Funding Information
- National Natural Science Foundation of China (81972175)
This publication has 30 references indexed in Scilit:
- Assessment of a Combined Panel of Six Serum Tumor Markers for Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor PrognosisAnnals of Surgical Oncology, 2016
- Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence SurvivalJournal of Clinical Oncology, 2015
- Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patientsThoracic Cancer, 2015
- Correlation between Serum Carcinoembryonic Antigen Level and Histologic Subtype in Resected Lung AdenocarcinomaAsian Pacific Journal of Cancer Prevention, 2015
- Micropapillary and solid subtypes of invasive lung adenocarcinoma: Clinical predictors of histopathology and outcomeThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Impact of Micropapillary Histologic Subtype in Selecting Limited Resection vs Lobectomy for Lung Adenocarcinoma of 2cm or SmallerJNCI: Journal of the National Cancer Institute, 2013
- Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancerLung Cancer, 2013
- Carcinoembryonic antigen (CEA) as tumor marker in lung cancerLung Cancer, 2012
- CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinomaBiomarkers, 2010